Pitfalls in diagnosis of Hepatitis B virus infection among adults nigerians

Nigerian Journal of Clinical Practice

Volumn 12, Issue 4, 2009, Pages 350-354

  Ola, S O ^a   Otegbayo, J A ^a   Yakubu, A ^a   Aje, A O ^a   Odaibo, G N ^a   Shokunbi, W ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Adults nigerians; Diagnosis; ELISA; HBV; Pitfalls

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; NEGRO; NIGERIA; PREVALENCE; VIROLOGY;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; NIGERIA; PREVALENCE; REAGENT KITS, DIAGNOSTIC; SEROEPIDEMIOLOGIC STUDIES;

EID: 72849119128     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hou J, Liu Z, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int. J. Med. Sci. 2005; 2: 50-57.
2. Ola SO, Otegbayo JA, Odaibo GN, Olaleye OD, Olubuyide IO. Serum hepatitis C virus and hepatitis B surface antigenaemia in Nigerian patients with acute icteric hepatitis. WestAfr.J.Med.2002; 21: 215-217.
3. Ndububa DA, Ojo OS, Adetiloye VA, Durosinmi MA, Olasode BJ, Famurewa OC et al. Chronic hepatitis in Nigerian patients: a study of 70 biopsy-proven cases. West Afr. J. Med. 2005; 24: 215-217.
4. Tong S, Kim KH, Chante C, Wands J, Li J. Hepatitis B Virus e Antigen Variants. Int. J. Med. Sci. 2005; 2: 2-7.
5. Okot FA. Viral hepatitis. E. Afr. Med. J. 1996; 73: 308-312.
6. Ola SO, Anomneze EE, Chukwuani CM, Ojo OS, Ndububa DA, Onyenekwe B et al. Interferon alfa-2a (Roferon-A) in the management of chronic hepatitis B infection: Results of an open prospective study in Nigerian patients. West Afr. J. Med. 2000; 19: 259-264.
7. Lesi OA, Kehinde MO, Omilabu SA. Prevalence of the Hepatitis Be Antigen in Nigerian patients with chronic liver disease Nig. Qt. J. Hosp. Med. 2004; 14: 1-4.
8. 8. Khalil LA, Elsheikh FS, Phrykian J, Phrykian S, Mitchell R. Prevalence of HBsAg among non cauterized groups of blood donors. E.Afr.Med.J. 1996; 73(11): 717-719. (Pubitemid 126353959)
9. Irshad M, Singh YN, Acharva SK. HBV-status in professional blood donors in north India. Trop. Gastroenterol. 1992; 13: 112-114
10. Otegbayo JA, Fasola FA, Abja A. Prevalence of hepatitis B surface and e antigens, risk factors for viral acquisition and serum transaminases among blood donors in Ibadan, Nigeria. Trop. Gastroenterol. 2003; 24: 196-197
11. 11. Odusanya OO, Alufohai FE, Meurice FP, Wellens R, Weil J, Ahonkhai VI. Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria. Int J Infect Dis. 2005 May; 9(3): 139-143 (Pubitemid 40523758)
12. Odusanya OO, Meurice FP, Hoet B. Nigerian medical students are at risk for hepatitis B infection. Trans R Soc Trop Med Hyg. 2007 May; 101(5): 465-468
13. Rate of Reported Hepatitis B by Age Group. United States, 1990. Http://www.cdc.gov/ncidod/diseases/hepatits/slideset/hep-b/hep-b.pdf.
14. Chandra R, Kapoor D, Agarwal SR, Malhotra V Sakhuja P, Sarin SK. Profile of asymptomatic chronic HBV infection in India. Indian J. Med. Res. 2002; 116: 50-57
15. Odemuyiwa SO, Mulders MN, Oyedele Ol, Ola SO, Odaibo GN, Olaleye DO et al. Phylogenetic analysis of new hepatitis B virus isolates from Nigeria supports endemicity of genotype E in West Africa. J Med. Virol. 2000; 165: 463-469.
16. Highleyman L. Natural History and Treatment of Chronic Hepatitis B: A Critical Evaluation of Standard Treatment Criteria and Endpoints. Http://www.hivandhepatitis.com/hep-b/news/2007/072007-a.html
17. Hepatitis B therapy Chart. http://www.hivandhepatitis.com/hep-b/news/ 2007/072007-a.html